Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource rightarrow Antibody rightarrow CEACAM6 rightarrow Polyclonal CEACAM6  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
Our Best Sellers moreseparator
 • SDCBP Antibody
 • USP29 Antibody
 • Parathyroid Hormone (PTH) ELISA Kit
 • myelin oligodendrocyte glycoprotein antibody (IgG) ELISA Kit
 • HFE Antibody
 • ZZZ3 Antibody
 • IgA ELISA Kit
 • 2-amino-5-formylamino-6-rib osylaminopyrimidin-4 (3H)-one 5'-... Recombinant Protein
 • TNFSF4 Antibody
 • Renin ELISA Kit
 • PRKRA Antibody
 • Kallikrein-14 (Klk14) Recombinant Protein
 • MAOA Antibody
 • BTF3 Antibody
 downarrow more ...
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

anti-CEACAM6 antibody :: Goat Carcinoembryonic Antigen (CEA) Polyclonal Antibody

Scan QR to view Datasheet Catalog #    MBS315469 anti-CEACAM6 antibody
Unit / Price
1 mL  /  $220 +1 FREE 8GB USB
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

Carcinoembryonic Antigen (CEA) (CEACAM6), Polyclonal Antibody

 Also Known As   

Goat anti CEA

 Product Synonym Names    Goat Antibody to Carcinoembryonic Antigen (CEA)
 Product Gene Name   

anti-CEACAM6 antibody

[Similar Products]
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 Chromosome Location    chromosome: 19; Location: 19q13.2
 3D Structure    ModBase 3D Structure for Q13985
Section Bar
 Clonality    Polyclonal
 Host    Goat
Section Bar
 Specificity    Carcinoembryonic Antigen (CEA)
 Form/Format    Neat, Liquid
 Concentration    Not determined
Titer: 1:200,000 (ELISA) (lot specific)
Section Bar
 Immunogen    Purified Human CEA
 Buffer    Not applicable
 Preservative    0.1% Sodium azide
 Important Note    Centrifuge before opening to ensure complete recovery of vial contents.
 Warnings    This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.
Section Bar
 Preparation and Storage    Short-term store at 2 to 8 degree C. Long term, aliquot and store at -20 degree C. Avoid multiple freeze/thaw cycles
 ISO Certification    Manufactured in an ISO 9001:2008 Certified Laboratory.
 Other Notes    Small volumes of anti-CEACAM6 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 Product Categories/Family for anti-CEACAM6 antibody    Polyclonal Antibodies for Cancer Research
NCBI/Uniprot data below describe general gene information for CEACAM6. It may not necessarily be applicable to this product.
 NCBI GI #    553222
 NCBI GeneID    4680
 NCBI Accession #    AAA51971.1 [Other Products]
Section Bar
 UniProt Primary Accession #    Q13985 [Other Products]
 UniProt Related Accession #    P40199; Q13985; Q14921; Q14922; Q53XP7 [Other Products]
 Molecular Weight    15,545 Da [Similar Products]
Table BarTOPTable Bar
 NCBI Official Full Name    carcinoembryonic antigen
 NCBI Official Synonym Full Names    carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
 NCBI Official Symbol    CEACAM6 [Similar Products]
 NCBI Official Synonym Symbols   
[Similar Products]
 NCBI Protein Information    carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
 UniProt Protein Name    Carcinoembryonic antigen
 Protein Family    Carcinoembryonic antigen-related cell adhesion molecule
 UniProt Gene Name    CEA [Similar Products]
 UniProt Entry Name    Q13985_HUMAN
Section Bar
 NCBI Summary for CEACAM6    Carcinoembryonic antigen (CEA; MIM 114890) is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180-kD form of CEA (Barnett et al., 1988 [PubMed 3220478]). For background information on the CEA family of genes, see CEACAM1 (MIM 109770).[supplied by OMIM]
Section Bar
 UniProt Comments for CEACAM6    CEACAM6: Belongs to the immunoglobulin superfamily. CEA family

Protein type: Membrane protein, integral; Membrane protein, GPI anchor

Chromosomal Location of Human Ortholog: 19q13.2

Cellular Component: integral to plasma membrane; plasma membrane

Molecular Function: protein binding

Biological Process: cell-cell signaling; blood coagulation; signal transduction; leukocyte migration
Table BarTOPTable Bar
 Research Articles on CEACAM6    1. CEACAM6-associated signaling pathways could be potential targets for the development of biomarkers to predict the response of patients to adenovirus-based therapies, as well as for the development of more potent adenovirus-based therapeutics
2. Because CEACAM6 acts as an antiapoptotic factor and stabilizes surfactant function, in addition to a putative role in innate defense against bacteria, we propose that it is a multifunctional alveolar protein
3. Data show that desensitization of neutrophils to any two CEACAMs, 1, 3, 6, or 8, results in selective desensitization to those two CEACAMs, while the cells remain responsive to the other two neutrophil CEACAMs.
4. CEACAM6 is overexpressed in borderline and invasive mucinous ovarian neoplasms.
5. findings suggest that CEA (CEACAM5) and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling.
6. All the leukemic samples showed overexpression of CEACAM6 and 8 when compared with normal granulocytes.
7. data support an important role for CEACAM6 in endocrine resistance in breast cancer, which can serve as a powerful predictor of future recurrence
8. Observational study of gene-disease association. (HuGE Navigator)
9. The expression of CEACAM6 in ADH lesions is strongly associated with the development of IBC, therefore, it can be applied as a diagnostic marker either singly or in combination with other marker(s) to predict IBC development in women with ADH lesions.
10. CEACAM6 is a biological tumor marker for epithelial ovarian cancers.
11. the results show that recognition of CEA and CEACAM6, but not CEACAM1, is accompanied by tight attachment to bacteria of cell surface microvilli-like extensions
12. For all tumors, the amount of CEACAM6 expressed was greater than that of CEACAM5, and reflected tumor histotype.
13. CEACAM6 subdomains involved in intercellular adhesion activity and subdomains involved in inhibition of cell differentation are identified and their respective activities are independently blocked.
14. overexpression among human malignancies, immunological targeting of this tumor antigen may have therapeutic applicability
15. Levels of CEACAM6 expression can modulate pancreatic adenocarcinoma cellular invasiveness in a c-Src-dependent manner
16. Data show that variants of Neisseria gonorrhoeae that bind to human carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) 1 and 6 failed to induce detachment and, instead, promoted enhanced host cell adhesion to the ECM.
17. CEACAM6 gene silencing reversed the acquired anoikis resistance of tumor cell lines and inhibited in vivo metastatic ability
18. CEACAM6 is an important determinant of pancreatic adenocarcinoma malignant cellular behavior
19. CD66c is regulated in a manner distinct from other myeloid antigens in childhood lymphoblastic leukemia
20. Overexpression of CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with anti-CEACAM6 antibodyDiseases associated with anti-CEACAM6 antibody
 Reference Product  PubMed Publications
 CEACAM1 antibody  >43 publications with CEACAM6 and CEACAM1
 CEACAM8 antibody  >16 publications with CEACAM6 and CEACAM8
 Disease Name  Pubmed Publications
 Neoplasms Antibodies  >66 publications with CEACAM6 and Neoplasms
 Adenocarcinoma Antibodies  >23 publications with CEACAM6 and Adenocarcinoma
 Inflammation Antibodies  >11 publications with CEACAM6 and Inflammation
 Lymphoma Antibodies  >9 publications with CEACAM6 and Lymphoma
 Breast Neoplasms Antibodies  >9 publications with CEACAM6 and Breast Neoplasms
 Lung Neoplasms Antibodies  >8 publications with CEACAM6 and Lung Neoplasms
 Stomach Neoplasms Antibodies  >8 publications with CEACAM6 and Stomach Neoplasms
 Leukemia, Myeloid, Acute Antibodies  >8 publications with CEACAM6 and Leukemia, Myeloid, Acute
 Necrosis Antibodies  >6 publications with CEACAM6 and Necrosis
 Neoplasms, Experimental Antibodies  >4 publications with CEACAM6 and Neoplasms, Experimental
Organs/Tissues associated with anti-CEACAM6 antibody
 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >5621 publications with CEACAM6 and Blood
 Lung Antibodies  >1783 publications with CEACAM6 and Lung
 Stomach Antibodies  >1037 publications with CEACAM6 and Stomach
 Skin Antibodies  >459 publications with CEACAM6 and Skin
 Intestine Antibodies  >454 publications with CEACAM6 and Intestine
 Pancreas Antibodies  >432 publications with CEACAM6 and Pancreas
 Muscle Antibodies  >348 publications with CEACAM6 and Muscle
 Kidney Antibodies  >307 publications with CEACAM6 and Kidney
 Bladder Antibodies  >248 publications with CEACAM6 and Bladder
 Prostate Antibodies  >233 publications with CEACAM6 and Prostate
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions